Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EsPhALL 2004
DRKS00005309Phase 3Completed
- Sponsor
- Matilde Tettamanti Research Center
- Start
- Dec 2013
- Modality
- Small Molecules
- Countries
- 8
01
Overview
Phase 3, randomised, open-label trial of imatinib in acute lymphoblastic leukemia (ALL) and chronic myelogenous leukemia (CML) (2 arms), sponsored by Matilde Tettamanti Research Center. Started Dec 2013; status: completed.
02
Drugs
03
Conditions
acute lymphoblastic leukemia (ALL)chronic myelogenous leukemia (CML)
Beyond the preview
Go deeper on DRKS00005309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00005309.